PerCellVac2

N/A

Report date: 2024/12/23 15:34:15

Base Information

Drug NamePerCellVac2

Drug Alias NamePerCellVac-2

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesBeijing Tricision Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBeijing Tricision Biotherapeutics Inc

Active IndicationsN/A

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A